31638 Tirzepatide for Sale
Compare supplier listings for Tirzepatide (CAS 2023788-19-2) — check price, grade and packaging, then open a product page or send an inquiry. View Suppliers
Tirzepatide Pharmaceutical Peptide | Wholesale | For Research Only
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
95%
-
Packaging:
10mg/package ,100mg/package
Vitamin K2,NAD+,Semaglutide,Tirzepatide,Sodium Glutathione
Tirzepatide Peptide Manufacturer | Stable Quality GMP | For Research Only
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
95%
-
Packaging:
10mg/package ,100mg/package
Vitamin K2,NAD+,Semaglutide,Tirzepatide,Sodium Glutathione
Tirzepatide Peptide Manufacturer | Bulk Export | For Research Only
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
95%
-
Packaging:
10mg/package ,100mg/package
Vitamin K2,NAD+,Semaglutide,Tirzepatide,Sodium Glutathione
Tirzepatide Raw Material Supplier | Global Export | For Research Only
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
95%
-
Packaging:
10mg/package ,100mg/package
Vitamin K2,NAD+,Semaglutide,Tirzepatide,Sodium Glutathione
High Purity Tirzepatide | R&D Raw Material API | For Research Only
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
95%
-
Packaging:
10mg/package ,100mg/package
Vitamin K2,NAD+,Semaglutide,Tirzepatide,Sodium Glutathione
Products You May Be Interested in
High Purity Tirzepatide | R&D Raw Material | For Research Only
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
95%
-
Packaging:
10mg/package ,100mg/package
Vitamin K2,NAD+,Semaglutide,Tirzepatide,Sodium Glutathione
Pharmaceutical-Grade Tirzepatide, Pharmacopoeia Compliant, Cardio-Friendly, Sufficient Stock
-
Price:
$78-85/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
95%
-
Packaging:
10mg/package ,100mg/package
Vitamin K2,NAD+,Semaglutide,Tirzepatide,Sodium Glutathione
Injectable/Oral Grade Tirzepatide, 97%-99% Purity, Customizable on Demand
-
Price:
$78-85/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
95%
-
Packaging:
10mg/package ,100mg/package
Vitamin K2,NAD+,Semaglutide,Tirzepatide,Sodium Glutathione
Tirzepatide Peptide API Powder | For Research Only
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
95%
-
Packaging:
10mg/package ,100mg/package
Vitamin K2,NAD+,Semaglutide,Tirzepatide,Sodium Glutathione
Permium peptide Tirzepatide weight loss and fitness high purity
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg/7mg/10mg/15mg*10vials/1kit
- Buying Tirzepatide on www.echemi.com where you will find large variety of good choices. Suppliers of 31638 Tirzepatide registered will be verified by the accurate information. Safe transaction of chemical will be made based on true information. We help you get chemicals in need continuously and meet registered Tirzepatide suppliers.
- The quality of Tirzepatide 2023788-19-2 will be secured by ECHEMI. The pursuit of high quality requires all partners of ECHEMI to be screened, whether its certificate, qualification or scale. Tirzepatide will reach global regulation and requirement of various regions. Further services on the whole supply chain can be provided with ECHEMI.
- We offer reasonable and fair market price of Tirzepatide to provide better products and services. Services of Tirzepatide like trade data and market price and insight can be subscribed on ECHEMI. You can enjoy the chemical supply chain services on ECHEMI. We will help you purchase Tirzepatide and run fast your business.
- •China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
- •Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
- •Novo Nordisk’s Semaglutide Faces Strong Competition: Eli Lilly’s Tirzepatide Officially Launched in China
- •Eli Lilly Revenue Reaches $31.5 Billion, Up 27%! Tirzepatide and Semaglutide Exceed $20 Billion
- •Novo Nordisk's 2024 Earnings Surge by 23%! Diabetes Drug Sales Skyrocket, but Facing Competition Pressure from Tirzepatide